HEPATIC STEATOSIS: AN AETIOHISTOPATHOLOGICAL STUDY

被引:1
|
作者
Metkar, Gauri Shrikrishna [1 ]
机构
[1] AJ Inst Med Sci & Res Ctr, Dept Pathol, Mangalore, India
关键词
Fatty Liver; Alcoholic Liver Disease; NASH;
D O I
10.14260/jemds/2016/808
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BACKGROUND Fatty liver disease, i.e. hepatic steatosis defined as hepatic lipid accumulation greater than 5-10% of liver weight. 1-3 has become a common health problem in both developed and developing countries. Morphologically fatty liver is of two types: microvesicular and macrovesicular. Macrovesicular steatosis is a chronic condition associated with various risk factors like alcoholism, diabetes mellitus, obesity, etc. The aim of present study was to analyse various aetiological factors associated with macrovesicular hepatic steatosis and find its correlation with the grade of steatosis. METHODOLOGY This retrospective and prospective study was conducted in histopathology laboratory of a tertiary health care centre in Mangalore, Karnataka, from 2009 to 2014; 120 cases of liver biopsies and autopsy liver tissue of adults (>= 18 years) showing histologically confirmed macrovesicular steatosis in >10% hepatocytes were analysed for aetiology and grade of steatosis. RESULT Hepatic steatosis was observed mainly in middle aged (31-50 years) males. ALD and non-alcoholic steatohepatitis (NASH) were most common causes followed by infections like TB, HCV, HBV, HIV and other causes like CPC (Chronic Passive Congestion) liver and drugs. Spearmen's correlation coefficient was used to analyse correlation between aetiology and grade of steatosis. ALD and NASH were most common causes for severe steatosis. ALD and NASH were also common causes for mild-to-moderate grade of steatosis. Mainly moderate-to-severe steatosis was found in association with TB, HCV, HBV, HIV. CPC cases predominantly showed moderate steatosis. The correlation between aetiology and grade of steatosis was found to be statistically significant. Drug induced steatosis was mostly severe grade, but the number of cases were too less to consider it statistically significant. CONCLUSION Various causes like ALD, NASH, TB, HCV, HBV and HIV infections, CPC and rarely drugs should be considered in cases of macrovesicular hepatic steatosis and histopathological sections of liver tissue should be studied extensively to rule out higher grades of steatosis.
引用
收藏
页码:3502 / 3505
页数:4
相关论文
共 50 条
  • [31] SKIP AREAS IN HEPATIC STEATOSIS - A SONOGRAPHIC-ANGIOGRAPHIC STUDY
    MARCHAL, G
    TSHIBWABWATUMBA, E
    VERBEKEN, E
    VANROOST, W
    VANSTEENBERGEN, W
    BAERT, A
    LAUWERIJNS, J
    [J]. GASTROINTESTINAL RADIOLOGY, 1986, 11 (02): : 151 - 157
  • [32] Hepatic glucose utilization in hepatic steatosis and obesity
    Keramida, Georgia
    Hunter, James
    Peters, Adrien Michael
    [J]. BIOSCIENCE REPORTS, 2016, 36
  • [33] Hepatic steatosis, carotid atherosclerosis and metabolic syndrome: the STEATO Study
    Claudio Carallo
    Gerardo Mancuso
    Gaetano Mauro
    Ferdinando Laghi
    Bruno Madafferi
    Concetta Irace
    Agostino Gnasso
    Faustina Scavelli
    Ferruccio Dell’Aquila
    Mosè Bartone
    Francesco Gullo
    Maria Ferraro
    Vitaliano Spagnuolo
    Maria Belmonte
    Antonio Ferrara
    Antonio Silvano Rotondaro
    Nicola Brandolino
    Francesca Parasporo
    Francesco Scopelliti
    [J]. Journal of Gastroenterology, 2009, 44 : 1156 - 1161
  • [34] Mitochondrial dysfunction in hepatic steatosis
    Pessayre, D
    Berson, A
    Fromenty, B
    Mansouri, A
    [J]. STEATOHEPATITIS (NASH AND ASH), 2001, 121 : 80 - 99
  • [35] Familial hypolipoproteinemia with hepatic steatosis
    Lammert, F
    Nguyen, HN
    [J]. DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2002, 127 (38) : 1964 - 1965
  • [36] LAPAROSCOPY VALUE IN THE HEPATIC STEATOSIS
    DELAREVILLA, L
    MARTINVIVALDI, R
    BUESO, FC
    [J]. REVISTA ESPANOLA DE LAS ENFERMEDADES DEL APARATO DIGESTIVO, 1982, 61 (03): : 218 - 224
  • [37] Hepatic steatosis in patients with acromegaly
    Koutsou-Tassopoulou, Andreani
    Papapostoli-Sklavounou, Ifigeneia
    Krawczyk, Marcin
    Friesenhahn-Ochs, Bettina
    Weber, Susanne N.
    Lammert, Frank
    Stokes, Caroline S.
    [J]. ENDOCRINOLOGY DIABETES & METABOLISM, 2019, 2 (04)
  • [38] Multinodular focal hepatic steatosis
    Gallarin Salamancaa, Isabel Maria
    Galeano Diaz, Francisco
    Rubio Fernandez, Alejandro
    Blanco Fernandez, Gerardo
    [J]. CIRUGIA ESPANOLA, 2016, 94 (04): : 240 - 241
  • [39] Hepatic and Cardiac Steatosis Are They Coupled?
    Bugianesi, Elisabetta
    Gastaldelli, Amalia
    [J]. HEART FAILURE CLINICS, 2012, 8 (04) : 663 - +
  • [40] Tamoxifen therapy and hepatic steatosis
    Coskun, U
    Törüner, FB
    Günel, N
    [J]. NEOPLASMA, 2002, 49 (01) : 61 - 64